LifeStance Health Group closed at $13.43 on Nov 5, down 5.49%, 5.5% below its 52-week closing high. Volume of 11.1M shares was 3.65× its 20-day average (well above normal).
Split-adjusted performance: +10.9% over one month, +51.8% over six months, +169.7% over one year.
In the quarter ended Jun 30, 2026, revenue was $435.35M, up 26.1% from a year earlier, with a net margin of 5.4%.
Short interest was 13.8M shares at the Oct 15 settlement, down 11.2% from the prior report (6.3% of float, 4.8 days to cover).